MEI Pharma Issued European Patent for Lead Mitochondrial Inhibitor Drug Candidate ME-344

[at noodls] – October 2, 2012 MEI Pharma Issued European Patent for Lead Mitochondrial Inhibitor Drug Candidate ME-344 San Diego – MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development … more

View todays social media effects on MEIP

View the latest stocks trending across Twitter. Click to view dashboard